Form 4: McKesson CFO Britt Vitalone Reports Routine Stock Transactions and RSU Vesting

McKesson Corporation's Executive Vice President and Chief Financial Officer, Britt J. Vitalone, reported multiple transactions involving company common stock, including the vesting of Restricted Stock Units (RSUs), tax withholdings, and a pre-planned sale.

Summary

• On May 23, 2025, Britt J. Vitalone acquired 1,475 shares of McKesson Common Stock at a price of $0, stemming from the vesting of Restricted Stock Units (RSUs).
• Concurrently on May 23, 2025, 581 shares were disposed of at $716.09 per share to cover tax obligations related to the RSU vesting.
• An additional 732 shares were sold on May 23, 2025, at $715.24 per share, pursuant to a Rule 10b5-1 pre-arranged trading plan established on November 9, 2024.
• On May 24, 2025, Vitalone acquired 1,623 shares of McKesson Common Stock at $0 per share due to another RSU vesting event.
• Following the May 24, 2025, RSU vesting, 639 shares were disposed of at $716.09 per share for tax withholding purposes.
• After these transactions, Mr. Vitalone directly beneficially owns 15,906.377 shares of Common Stock.
• Additionally, Mr. Vitalone indirectly owns 550.1508 shares through the McKesson Corporation 401(k) Retirement Savings Plan.
• The RSUs vesting on May 23, 2025, were part of a grant that vests in three equal installments on May 23, 2024, May 23, 2025, and May 23, 2026.
• The RSUs vesting on May 24, 2025, were part of a grant that vested in three equal installments on May 24, 2023, May 24, 2024, and May 24, 2025.

Sentiment

Score: 6

Explanation: The document reports routine, pre-planned insider transactions (RSU vesting, tax withholdings, and 10b5-1 sales). While a sale by a CFO could be seen as slightly negative, the pre-planned nature and RSU vesting context make it a neutral to slightly positive event, reflecting standard executive compensation and stock management.

Positives

• The vesting of Restricted Stock Units (RSUs) indicates the successful achievement of performance or tenure milestones, aligning executive incentives with long-term company performance.
• The use of a Rule 10b5-1 plan for stock sales demonstrates a pre-arranged, compliant approach to insider transactions, reducing concerns about opportunistic trading.

Negatives

• The sale of shares by a key executive, even if pre-planned, reduces their direct ownership stake in the company.

Risks

• No specific risks are detailed in this Form 4 filing beyond the inherent market risks associated with holding equity.

Future Outlook

The document indicates future RSU vesting events, with a portion of the RSUs granted on May 23, 2025, scheduled to vest on May 23, 2026.

Management Comments

• The sale of 732 shares on May 23, 2025, was made pursuant to a previously adopted plan dated November 9, 2024, in compliance with Rule 10b5-1(c).

Industry Context

This Form 4 filing reflects routine executive compensation and stock management practices common across publicly traded companies, particularly within the healthcare distribution and technology sector where McKesson operates. Such transactions are standard for executives managing their equity holdings and tax obligations.

Comparison to Industry Standards

• The use of Rule 10b5-1 plans for executive stock sales is a widely accepted corporate governance practice, aligning with industry standards for transparent and pre-planned insider transactions.
• The structure of RSU vesting over multiple years is a common long-term incentive mechanism used by large corporations like McKesson to retain executives and align their interests with shareholder value creation, comparable to practices at peer companies in the pharmaceutical distribution or healthcare services sectors such as Cardinal Health (CAH) or AmerisourceBergen (ABC).

Stakeholder Impact

• Shareholders: The transactions represent routine executive compensation and stock management, with minimal direct impact on share price given their pre-planned nature. The sale of shares by the CFO slightly reduces insider ownership.
• Employees: The RSU vesting reflects standard executive compensation practices, which are part of the broader compensation framework within the company.

Next Steps

• A portion of the Restricted Stock Units (RSUs) granted on May 23, 2025, will vest on May 23, 2026.

Key Dates

Keywords

McKesson, MCK, Form 4, Insider Trading, Stock Sale, RSU, Restricted Stock Units, Executive Compensation, Beneficial Ownership, 10b5-1 Plan, CFO